Literature DB >> 30094299

Genital ulcers in an immunocompromised man.

Paul Curtiss1, Gabriela Cobos1, Rachel Hoffmann1, Nicole Seminara1, Tracey Liebman1, Nooshin Brinster1, Kristen Lo Sicco1.   

Abstract

Entities:  

Keywords:  CMV, cytomegalovirus; CNS, central nervous system; CSF, cerebrospinal fluid; IV, intravenous; LGV, lymphogranuloma venereum; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; cytomegalovirus; immunosuppression; renal transplant

Year:  2018        PMID: 30094299      PMCID: PMC6070680          DOI: 10.1016/j.jdcr.2017.10.024

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.
A 72-year-old man with a history of type 2 diabetes, renal transplant, long-term immunosuppression with prednisone and tacrolimus, and a recent diagnosis of posttransplant lymphoproliferative disorder, presented with a 2-week history of worsening headaches and blurry vision. Physical examination was notable for a left facial droop and 4 genital ulcerations: 2 on the left medial thigh and 2 on the left lateral scrotum. The ulcerations had well-defined pink raised borders and a thin yellow membrane overlying the base (Fig 1). Results of a punch biopsy are shown (Fig 2).
Fig 1
Fig 2
Question 1: What is the most likely diagnosis? Chancroid Syphilis Cytomegalovirus (CMV) Behcet disease Lymphogranuloma venereum (LGV) Chancroid – Incorrect. Haemophilus ducreyi causes genital ulcers in both immunocompetent and immunocompromised hosts, but is associated with lymphadenopathy, not focal neurologic deficits. Syphilis – Incorrect. Treponema pallidum causes genital ulcers and neurologic symptoms from primary and tertiary syphilis, respectively. Primary and tertiary syphilis do not occur concurrently and are typically separated by years. Given the patient's acute presentation with both neurologic and cutaneous, syphilis is less likely than CMV. Histopathology of primary syphilis typically shows acantholysis of the epidermis and lymphocytic infiltrate with numerous plasma cells. CMV inclusion bodies would not be present. CMV – Correct. Cutaneous presentations of CMV in the immunocompromised individual include petechial, nodular, urticarial, vesiculobullous, and papulopustular eruptions, as well as mucosal ulcerations. Of these presentations, genital ulcerations are the most common and well described in the immunosuppressed population.1, 2, 3 Histopathology (Fig 2, B) shows a dermal cell with an enlarged nucleus containing a round, eosinophilic globule and granular cytoplasm. This inclusion body is characteristic of CMV infection. Behcet disease – Incorrect. Behcet disease can cause genital aphthae and central nervous system (CNS) vasculitis but is not associated with immunosuppression. Generally, patients present with oral apthae, uveitis, or cutaneous vasculitis. The patient's ongoing treatment with prednisone and tacrolimus would have therapeutic activity against Behcet disease. LGV – Incorrect. Chlamydia trachomatis manifesting as LGV is more common in HIV-infected individuals than renal transplant recipients. LGV is associated with local lymphadenopathy and not CNS disease. Question 2: What is the preferred treatment option for this disease? Intravenous (IV) acyclovir Prednisone Azithromycin Benzathine penicillin G IV ganciclovir IV acyclovir – Incorrect. IV acyclovir is the preferred treatment for herpes simplex but has limited activity against CMV. Prednisone – Incorrect. Prednisone is a reasonable treatment for ulcers caused by Behcet disease. Azithromycin – Incorrect. Azithromycin is the first-line treatment for chancroid. Benzathine penicillin G – Incorrect. Benzathine penicillin G is the preferred treatment for primary syphilis. IV ganciclovir – Correct. Recommended management of CMV in the immunocompromised host is treatment with IV ganciclovir or oral valganciclovir. As patients with previous CMV disease are at elevated risk for recurrence, subsequent prophylaxis with oral valganciclovir should continue for 1 to 3 months after clearance of infection. Question 3: What test is most likely to diagnose the etiology of the patient's CNS disease? Cerebrospinal fluid polymerase chain reaction (CSF PCR) Brain magnetic resonance imaging (MRI) Empiric treatment, no additional testing is necessary Blood PCR CSF culture CSF PCR – Correct. CSF PCR is the most sensitive and specific test for CMV involving the CNS.4, 5 Brain MRI – Incorrect. MRI is appropriate in the immunocompromised individual presenting with focal neurologic deficits and a history of posttransplant lymphoproliferative disorder, but it is less sensitive for diagnosing CNS CMV than CSF PCR. Empiric treatment, no additional testing is necessary – Incorrect. Given the patient's CMV genital ulcers, he should receive treatment with IV ganciclovir or oral valganciclovir. This does not obviate the need for further workup for his neurologic symptoms. Blood PCR – Incorrect. Patients are generally viremic before experiencing disseminated CMV disease, and blood PCR is often positive. This finding, however, is not specific for CNS infection. CSF culture – Incorrect. CMV culture is often highly sensitive and specific for detecting CMV in tissue specimens but is less sensitive in detecting CMV in the CSF.
  5 in total

1.  Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.

Authors:  Camille N Kotton; Deepali Kumar; Angela M Caliendo; Anders Asberg; Sunwen Chou; Lara Danziger-Isakov; Atul Humar
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

Review 2.  Cytomegalovirus infection in normal and immunocompromised humans. A review.

Authors:  F Drago; M G Aragone; C Lugani; A Rebora
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

Review 3.  CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Authors:  Matthias Maschke; Oliver Kastrup; Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.

Authors:  Y-L Choi; J-A Kim; K-T Jang; D-S Kim; W-S Kim; J-H Lee; J-M Yang; E-S Lee; D-Y Lee
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

Review 5.  Cytomegalovirus Scrotal Ulcer in a Renal Transplant Patient.

Authors:  Rebeca Pinca; Richard I Crawford; Sheila Au
Journal:  J Cutan Med Surg       Date:  2016-05-18       Impact factor: 2.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.